文献速递脑血管病神经重症与神经感染

汇总分析提示基于导管的血肿清除术对脑出血有益

Pooled analysis suggests benefit of catheter-based hematoma removal for intracerebral hemorrhage.
PubMed 文献 · Neurology · 2019-03-20

包含基线NIHSS、年龄和血肿体积的模型拟合最佳(校正R²=0.89),纤维蛋白溶解辅助血肿清除的早期研究显示最有前景,趋向改善功能结局且未提示死亡率增加。

要点

  • 基于基线NIHSS、年龄和血肿体积的模型对脑出血功能结局预测拟合最佳(校正R²=0.89)。
  • 该方法可识别最终后期试验为阴性的早期治疗。
  • 早期纤维蛋白溶解辅助血肿清除研究显示最有前景,支持进一步研究。

核心结论

  • 成功建立脑出血结局模型,可识别注定阴性的干预并发现一个有前景的干预。

研究设计与样本

  • 从多个图书馆数据库识别符合条件的临床试验和大样本病例系列。
  • 在p=0.1水平生成模型统计区间,以筛选各试验结局与预期结局的比较。

主要发现

  • 包含基线NIHSS、年龄和血肿体积的模型拟合最佳(校正R²=0.89)。
  • 所有最终后期试验为阴性的早期治疗均被该方法识别为阴性。
  • 早期纤维蛋白溶解辅助血肿清除研究显示最有前景,趋向改善功能结局且未提示死亡率增加。

关键数值与推荐

  • 功能结局以改良Rankin量表评分评估。
  • 模型统计区间在p=0.1水平生成。
  • 包含基线NIHSS、年龄和血肿体积的模型校正R²=0.89。

临床怎么用

  • 该结局模型可在多中心试验前帮助优先分配资源。
  • 早期纤维蛋白溶解辅助血肿清除的结果支持进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop models of outcome for intracerebral hemorrhage (ICH) to identify promising and futile interventions based on their early phase results without need for correction for baseline imbalances. METHODS: We developed a pooled outcome model from the control arms of randomized control trials and tested different interventions against the model at comparable baseline conditions. Eligible clinical trials and large case series were identified from multiple library databases. Models based on baseline factors reported in the control arms were tested for the ability to predict functional outcome (modified Rankin Scale score) and mortality. Interventions were grouped into blood pressure control, fibrinolytic-assisted hematoma evacuation, hemostatic medications, and neuroprotective agents. Statistical intervals around the model were generated at the p = 0.1 level to screen how each trial's outcome compared to expected outcome. RESULTS: Fourteen control arms with 3,386 patients were used to develop 7 alternate models for functional outcome. The model incorporating baseline NIH Stroke Scale, age, and hematoma volume yielded the best fit (adjusted R 2 = 0.89). All early phase treatments that eventually resulted in negative late phase trials were identified as negative by this method. Early phase fibrinolytic-assisted hematoma evacuation studies showed the most promise trending toward improved functional outcome with no suggestion of an increase in mortality, supporting its further study. CONCLUSIONS: We successfully developed an outcome model for ICH that identified interventions destined to be negative while identifying a promising one. Such an approach may assist in prioritizing resources prior to multicenter trial.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Mandava P, Murthy SB, Shah N, et al. Pooled analysis suggests benefit of catheter-based hematoma removal for intracerebral hemorrhage. Neurology. 2019. PMID: 30894441. doi:10.1212/WNL.0000000000007269

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。